Pharmaceuticals Market in Turkey 2011-2015

Introduction

TechNavio's analysts forecast the Pharmaceuticals market in Turkey to grow at a CAGR of 14.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the adoption of the Healthcare Transformation Program in Turkey. The Pharmaceuticals market in Turkey has also been witnessing the entry of foreign players. However, the low per capita spending on healthcare could pose a challenge to the growth of this market.

TechNavio's report, the Pharmaceuticals Market in Turkey 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on Turkey; it also covers Pharmaceuticals market landscape, and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Abdi Ibrahim, Bilim Pharmaceuticals, Novartis AG, and Pfizer Inc.

Other vendors mentioned in the report: Abbott Laboratories, Aliraif Pharmaceutical, AstraZeneca plc, Aventis Pharma Ltd, Bayer AG, Biofarma Pharmaceutical, Deva Pharmaceuticals Inc., Eastpharma Ltd., Eczacibasi Pharmaceuticals, GlaxoSmithKline plc, Menarini Raunaq Pharma Ltd, Merck & Co Inc, Mustafa Nevzat Pharmaceuticals, Nobel llac, Roche Diagnostics, Sanofi S.A., Sanovel Pharmaceuticals Inc., and Santa Farma Pharmaceuticals.

Key questions answered in this report:

• What will the market size be in 2015 and at what rate will it grow?
• What key trends is this market subject to?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the opportunities and threats faced by each of these key vendors?
• What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

Table of Contents

01. Executive Summary

02. Introduction

03. Market Coverage

• Market Overview
• Key Offerings

04. Market Landscape

• 04.1. Overall Pharmaceuticals Market in Turkey
  • Market Size and Forecast

• 04.2. Pharmaceuticals Market in Turkey by Product Segmentation

• 04.3. Prescription Drugs Market in Turkey
  • Market Size and Forecast

• 04.4 Patented Drugs Market in Turkey
• Market Size and Forecast

• 04.5. Generic Drugs Market in Turkey
  • Market Size and Forecast

• 04.6. Over-the-counter Drugs Market in Turkey
• 04.7. Health Personnel Employed in Turkey
• 04.8. Pharmaceuticals Market in Turkey by Key Market Applications
• 04.9. Pharmaceuticals Market in Turkey by Key Therapeutic Areas
• 04.10. Five Forces Analysis

05. Rate of Incidence and Prevalence

• Diabetes
• Cardiovascular Disease
• Arthritis
• Cancer
• Heart Disease
• Thyroid Disorders

06. Vendor Landscape

• 06.1. Vendor Landscape of the Pharmaceuticals Market in Turkey by Type of Vendors
• 06.2. Vendor Landscape of the Pharmaceuticals Market in Turkey by Revenue
• 06.3. Vendor Landscape of the Pharmaceuticals Market in Turkey by Volume

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

• Impact of Drivers on End-user Category

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis

• 13.1. Abdi Ibrahim Pharmaceuticals
  • Business Overview
  • SWOT Analysis

• 13.2. Novartis International AG
  • Business Overview
  • SWOT Analysis

• 13.3. Bilim Pharmaceuticals
  • Business Overview
  • SWOT Analysis

• 13.4. Pfizer Inc.
  • Business Overview
  • SWOT Analysis

14. Other Reports in this Series

• Exhibit 1: Pharmaceuticals Market in Turkey 2011-2015 (US$ million)
• Exhibit 2: Pharmaceuticals Market in Turkey by Product Segmentation
• Exhibit 3: Pharmaceuticals Market in Turkey by Share of Product Segmentation 2011-2015 (Percent)
• Exhibit 4: Prescription Drugs Market in Turkey 2011-2015 (US$ million)
• Exhibit 5: Prescription Drugs Market in Turkey 2011-2015 (million boxes)
• Exhibit 6: Prescription Drugs Market in Turkey by Product Segmentation
• Exhibit 7: Prescription Drugs Market in Turkey by Product Segmentation 2011 (Percent)
• Exhibit 8: Patented Drugs Market in Turkey 2011-2015 (US$ million)
• Exhibit 9: Patented Drugs Market in Turkey 2011-2015 (million boxes)
• Exhibit 10: Generic Drugs Market in Turkey 2011-2015 (US$ million)
• Exhibit 11: Generic Drugs Market in Turkey 2011-2015 (million boxes)
• Exhibit 12: OTC Drugs Market in Turkey 2011-2015 (US$ million)
• Exhibit 13: Pharmaceuticals Market in Turkey by Key Personnel Employed 2011
• Exhibit 14: Pharmaceuticals Market in Turkey by Key Market Applications 2011
• Exhibit 15: Pharmaceuticals Market in Turkey by Key Therapeutic Areas 2011
• Exhibit 16: Pharmaceuticals Market in Turkey by Type of Vendors 2011
• Exhibit 17: List of Top 10 International and Domestic Pharmaceutical Companies in Turkey
• Exhibit 18: Pharmaceuticals Market in Turkey by Vendor Segmentation Based on Revenue 2011
• Exhibit 19: Pharmaceuticals Market in Turkey by Vendor Segmentation Based on Volume 2011

Pharmaceuticals Market in Turkey 2011-2015 published by Infiniti Research Limited (Technavio) in August 9, 2012. This report consists of Pages: 51 and the price starts from US $ 2000.